Registry-based Non-interventional Analysis of Advanced/Metastatic Renal Carcinoma Treatment Patterns and Outcomes in the Hospital District of Southwest Finland.

Number of Participants According to Co-Diagnoses After Index

时间窗: Up to 3 years after index date

Number of participants according to co-diagnoses up to 3 years after participant's index were reported in this outcome measure. Index date was defined as the date of treatment initiation for mRCC. Co-diagnoses were based on ICD-10 codes. One participant may have more than one co-diagnoses.

Body Mass Index (BMI)

时间窗: At index

BMI of participants at index was reported in this outcome measure. Index date was defined as the date of treatment initiation for mRCC.

Mean Outpatient Visits and Emergent Room Visits Per Patient Year

时间窗: Up to maximum of 12 years (retrospective data collection of 1 month)

The number of outpatient visits and emergency room (ER) visits per patient year for all contacts, disease-specific contacts and other contacts were reported in this outcome measure. All contacts included disease specific contacts and other contacts. Per patient year was defined as total sum of events divided by the total sum of follow-up length of the participants.

Number of Participants According to Co-Diagnoses Before Index

时间窗: 3 years prior to index date

Number of participants according to co-diagnoses 3 years before participant's index were reported in this outcome measure. Index date was defined as the date of treatment initiation for mRCC. Co-diagnoses were based on International Classification of Diseases 10th revision (ICD-10) codes. One participant may have more than one co-diagnoses.

Mean Number of Hospitalizations Per Patient Year

时间窗: Up to maximum of 12 years (retrospective data collection of 1 month)

The number of hospitalization visits per patient year for all contacts, disease-specific contacts and other contacts were reported in this outcome measure. All contacts included disease specific contacts and other contacts. Per patient year was defined as total sum of events divided by the total sum of follow-up length of the participants.

Mean Number of Procedures and Surgeries Per Patient Year

时间窗: Up to maximum of 12 years (retrospective data collection of 1 month)

Number of procedures and surgeries per patient year were reported in this outcome measure. Per patient year was defined as total sum of events divided by the total sum of follow-up length of the participants.

Number of Participants According to Treatment

时间窗: From initiation of treatment until death, moved outside of HDSF or end of study (maximum up to 12 years)

Number of participants receiving each treatment per treatment line were reported in this outcome measure.

Number of Participants According to Treatment Per Treatment Line Between 2010 to 2017

时间窗: Anytime between January 2010 to December 2017 (maximum up to 8 years)

Number of participants according to treatment per treatment line between 2010 to 2017 were reported in this outcome measure.

Number of Participants According to Treatment Per Treatment Line Between 2018 to 2021

时间窗: Anytime between January 2018 to December 2021 (maximum up to 4 years)

Number of participants according to treatment per treatment line between 2018 to 2021 were reported in this outcome measure.

Mean Number of Laboratory Days Per Patient Year

时间窗: Up to maximum of 12 years (retrospective data collection of 1 month)

Number of laboratory days per patient year were reported in this outcome measure. Per patient year was defined as total sum of events divided by the total sum of follow-up length of the participants.

Mean Number of Laboratory Days Per Patient Year Stratified by International Metastatic Database Consortium (IMDC) Risk Category

时间窗: Up to maximum of 12 years (retrospective data collection of 1 month)

Number of laboratory days per patient year stratified by IMDC risk category were reported in this outcome measure. IMDC risk category included Score 0= favorable risk, no missing values allowed; Score 1-2= intermediate risk, total score=1: maximum 1 risk factor can have missing value, total score=2: no missing values allowed; Score 3-6= poor risk, maximum 3 risk factors allowed to have missing values; Unknown risk= when none of the above risk categories could be assigned. Per patient year was defined as total sum of events divided by the total sum of follow-up length of the participants.

Number of Participants Classified According to Karnofsky Performance Status (KPS) Stratified by IMDC Risk Category

时间窗: At index

KPS:used for rating activities of daily living on 11-step scale from 0-100,higher score=participant better able to carry daily activities.Score:100=normal no complaints;no disease evidence,90=able to carry normal activity;minor signs/symptoms of disease,80=normal activity with effort;some signs/symptoms, 70=cares for self;unable to carry normal activity,60=required occasional assistance,able to care for personal needs,50=required considerable assistance \& frequent medical care,40=disabled;required special care/assistance,30=severely disabled;hospital admission indicated;20=very sick;hospital admission necessary,10=moribund \& 0=dead.IMDC risk category:0=favorable risk,no missing values allowed;1-2=intermediate risk,total score=1:max 1 risk factor could have missing value,total score=2:no missing values allowed;3-6=poor risk,max 3 risk factors allowed to have missing values; Unknown=none of the above risk categories could be assigned.Index date=date of treatment initiation for mRCC.

Number of Participants Classified According to Pathological Diagnosis (PAD) Histology

时间窗: At index

Number of participants classified according to PAD were reported in this outcome measure. Histology included chromophobe renal cell carcinoma, clear cell renal cell carcinoma, oncocytoma renal cell carcinoma, papillary renal cell carcinoma, other (chromophobe, oncocytoma, and papillary renal cell carcinoma included if not reported separately) and missing. Index date was defined as the date of treatment initiation for mRCC.